Efficacy of Ravuconazole in Treatment of Systemic Murine Histoplasmosis

AUTOR(ES)

Clemons, K. V.

FONTE

American Society for Microbiology

RESUMO

Ravuconazole (RCZ) was evaluated for efficacy in comparison to fluconazole (FCZ) and itraconazole (ITZ) in murine models of disseminated histoplasmosis. All regimens tested prolonged survival (P < 0.05 to 0.0001). At equivalent doses of 50 mg/kg of body weight, RCZ and ITZ were equally effective and RCZ was more effective than FCZ (P = 0.02). Clearance of fungal burden from the livers and spleens of mice showed RCZ and ITZ at doses of 50 mg/kg to be efficacious but not curative. These data indicate that RCZ should be studied further.

Documentos Relacionados

• Efficacy of Nikkomycin Z in the Treatment of Murine Histoplasmosis
• Efficacy of the triazole D0870 in a murine model of systemic histoplasmosis.
• Efficacy of Liposomal Amphotericin B in Treatment of Systemic Murine Fusariosis
• Efficacy of Ravuconazole in Treatment of Mucosal Candidosis in SCID Mice
• In vivo oral efficacy of levofloxacin for treatment of systemic Pseudomonas aeruginosa infections in a murine model of septicemia.